{"id":"fortrans","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Abdominal bloating"},{"rate":null,"effect":"Abdominal cramping"},{"rate":null,"effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fortrans works by creating an osmotic gradient in the intestinal lumen, which pulls water from the bloodstream into the bowel. This increases stool bulk and promotes peristalsis, leading to bowel cleansing. It is commonly used for bowel preparation prior to colonoscopy or other gastrointestinal procedures.","oneSentence":"Fortrans is a polyethylene glycol (PEG)-based osmotic laxative that draws water into the bowel to promote bowel evacuation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:13:22.137Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bowel cleansing prior to colonoscopy or other gastrointestinal procedures"}]},"trialDetails":[{"nctId":"NCT03562884","phase":"PHASE3","title":"Efficacy, Safety and Tolerability of a New Bowel Cleansing Preparation (BLI800) in Adult Subjects Undergoing Colonoscopy","status":"COMPLETED","sponsor":"Ipsen","startDate":"2018-07-01","conditions":"Diagnosis Disease","enrollment":297},{"nctId":"NCT02321462","phase":"PHASE3","title":"Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy","status":"COMPLETED","sponsor":"Ipsen","startDate":"2015-03","conditions":"Bowel Cleansing","enrollment":296},{"nctId":"NCT01788709","phase":"PHASE4","title":"PEG-Electrolyte Solution (FORTRANS®) With Mentholyptus Drops (Halls®) Versus Reduced Volume Ascorbic Acid Supplemented PEG-Electrolyte (MoviPrep®) in Colonoscopy Preparation","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2013-01","conditions":"Bowel Cleansing in Preparation for Colonoscopy","enrollment":200},{"nctId":"NCT01541683","phase":"NA","title":"The Effect of Mentholyptus Drops on the Palatability of PEG-Electrolyte Solution","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2012-01","conditions":"Colon Cancer","enrollment":99}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Fortrans®","genericName":"Fortrans®","companyName":"Ipsen","companyId":"ipsen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fortrans is a polyethylene glycol (PEG)-based osmotic laxative that draws water into the bowel to promote bowel evacuation. Used for Bowel cleansing prior to colonoscopy or other gastrointestinal procedures.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}